Clinical Trial

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

Study acronym: ANGIO-STEMI
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.
Trial Details
NCT Number NCT06586424
Lead Sponsor Universitas Diponegoro
Conditions ST-segment Elevation Myocardial Infarction (STEMI)
Enrollment 80 participants
Start Date 2024-01-01
Primary Completion 2024-06-30 (estimated)
Study Completion 2024-10-05 (estimated)
Updated on ClinicalTrials.gov 2024-09-19